Statement Of Investor Complaints For The Quarter Ended 31St December 2017
Information relating to complaints (regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) for the Quarter ended 31st December, 2017. Broker's Call
Motilal OswalGranules India (Buy)CMP: 131Target: 200We recently hosted the management of Granules India at our Mid-cap conference. We surmise that the joint venture business will be impacted in... Bullish on these 2 auto stocks: Yogesh Mehta
Aurobindo Pharma and Granules india are the two pharma stocks worth betting on Fixed Record Date For Payment Of Second Interim Dividend For The FY 2017-18
Intimation of Record Date for payment of Second Interim Dividend for the FY 2017-18 Fixed Record Date For Payment Of Second Interim Dividend For The FY 2017-18
Intimation of Record Date for payment of Second Interim Dividend for the FY 2017-18 